<div id="readability-page-1">04:01 PM EST, 12/08/2025 (MT Newswires) -- Health care stocks declined late Monday afternoon, with the NYSE Health Care Index down 1.1% and the Health Care Select Sector SPDR Fund (XLV) falling 1.2%.The iShares Biotechnology ETF (IBB) decreased 0.5%.In corporate news, Kamada ( KMDA ) shares dropped 5% after it said Monday that it will discontinue the phase 3 trial of inhaled AAT for the treatment of Alpha-1 Antitrypsin Deficiency due to the &#34;low likelihood of a successful efficacy outcome.&#34;BiomX ( PHGE ) tumbled 36% after it reported a discontinuation of a phase 2b trial of nebulized phage therapy, BX004, in patients with CF associated with chronic Pseudomonas aeruginosa infections.STAAR Surgical ( STAA ) shares fell 7% after the company said Monday the go-shop period under its merger agreement with Alcon ( ALC ) has expired with no competing proposals received. Alcon ( ALC ) was down 2.1%.PROCEPT BioRobotics ( PRCT ) still has a large market opportunity for its aquablation technology to treat benign prostatic hyperplasia, but utilization growth has slowed, BofA Securities said in a report. It downgraded the stock to neutral from buy and cut its price target to $38 from $55. PROCEPT fell 4.5%. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

STAA

PRCT

PHGE

KMDA

Health care stocks fell late Monday afternoon, with the NYSE Health Care Index down 1.1% and the Health Care Select Sector SPDR Fund (XLV) dropping 1.2%. Kamada shares decreased 5% due to discontinuing a trial, BiomX tumbled 36% after halting a phase 2b trial, STAAR Surgical fell 7% post-merger period expiration, and PROCEPT BioRobotics dropped 4.5% following a stock downgrade by BofA Securities.

Sector Update: Health Care Stocks Fall Late Afternoon